These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23296919)

  • 1. Neuroinflammation: beneficial and detrimental effects after traumatic brain injury.
    Finnie JW
    Inflammopharmacology; 2013 Aug; 21(4):309-20. PubMed ID: 23296919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
    Kumar A; Loane DJ
    Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats.
    Wei HH; Lu XC; Shear DA; Waghray A; Yao C; Tortella FC; Dave JR
    J Neuroinflammation; 2009 Aug; 6():19. PubMed ID: 19656406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection for traumatic brain injury.
    Loane DJ; Stoica BA; Faden AI
    Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallic acid improved behavior, brain electrophysiology, and inflammation in a rat model of traumatic brain injury.
    Sarkaki A; Farbood Y; Gharib-Naseri MK; Badavi M; Mansouri MT; Haghparast A; Mirshekar MA
    Can J Physiol Pharmacol; 2015 Aug; 93(8):687-94. PubMed ID: 26222320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies negating neuroinflammation after brain trauma.
    Hellewell S; Semple BD; Morganti-Kossmann MC
    Brain Res; 2016 Jun; 1640(Pt A):36-56. PubMed ID: 26740405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury.
    Pu B; Xue Y; Wang Q; Hua C; Li X
    Mol Med Rep; 2015 Sep; 12(3):3704-3710. PubMed ID: 26004757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc in traumatic brain injury: from neuroprotection to neurotoxicity.
    Morris DR; Levenson CW
    Curr Opin Clin Nutr Metab Care; 2013 Nov; 16(6):708-11. PubMed ID: 23945221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline but not tigecycline is neuroprotective and reduces the neuroinflammatory response induced by the superimposition of sepsis upon traumatic brain injury.
    Adembri C; Selmi V; Vitali L; Tani A; Margheri M; Loriga B; Carlucci M; Nosi D; Formigli L; De Gaudio AR
    Crit Care Med; 2014 Aug; 42(8):e570-82. PubMed ID: 24810523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant, anti-inflammatory and neuroprotective actions of resveratrol after experimental nervous system insults. Special focus on the molecular mechanisms involved.
    Miguel CA; Noya-Riobó MV; Mazzone GL; Villar MJ; Coronel MF
    Neurochem Int; 2021 Nov; 150():105188. PubMed ID: 34536545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury.
    Laskowitz DT; McKenna SE; Song P; Wang H; Durham L; Yeung N; Christensen D; Vitek MP
    J Neurotrauma; 2007 Jul; 24(7):1093-107. PubMed ID: 17610350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches.
    Prabhakar NK; Khan H; Grewal AK; Singh TG
    Int Immunopharmacol; 2022 Jul; 108():108902. PubMed ID: 35729835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma.
    Kempuraj D; Thangavel R; Kempuraj DD; Ahmed ME; Selvakumar GP; Raikwar SP; Zaheer SA; Iyer SS; Govindarajan R; Chandrasekaran PN; Zaheer A
    Biofactors; 2021 Mar; 47(2):190-197. PubMed ID: 33098588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen-rich water attenuates brain damage and inflammation after traumatic brain injury in rats.
    Tian R; Hou Z; Hao S; Wu W; Mao X; Tao X; Lu T; Liu B
    Brain Res; 2016 Apr; 1637():1-13. PubMed ID: 26826009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
    Marklund N; Hillered L
    Br J Pharmacol; 2011 Oct; 164(4):1207-29. PubMed ID: 21175576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.
    McConeghy KW; Hatton J; Hughes L; Cook AM
    CNS Drugs; 2012 Jul; 26(7):613-36. PubMed ID: 22668124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relevance of the inflammatory response in the injured brain].
    Schmidt OI; Leinhase I; Hasenboehler E; Morgan SJ; Stahel PF
    Orthopade; 2007 Mar; 36(3):248, 250-8. PubMed ID: 17333066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational agents for treatment of traumatic brain injury.
    Xiong Y; Zhang Y; Mahmood A; Chopp M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
    Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
    Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.